2020
DOI: 10.3389/fonc.2020.571516
|View full text |Cite
|
Sign up to set email alerts
|

Crosstalk Between Mesenchymal Stromal Cells and Tumor-Associated Macrophages in Gastric Cancer

Abstract: Tumor microenvironment (TME) consisting of distinct cell types including stromal cells and immune cells has recently emerged as a pivotal player in tumor development and progression. Mesenchymal stromal cells (MSCs) and tumor-associated macrophages (TAMs) are two representative cells in the TME with plastic properties. This review will focus on the evolution of phenotypes and functions of either MSCs or TAMs, which is “educated” by the TME, as well as interactions between MSCs and TAMs contributing to the dist… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
21
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(22 citation statements)
references
References 81 publications
1
21
0
Order By: Relevance
“…Our study identified the TME-related gene PLXDC2 in a highstromal population and had a prognostic signature correlated to the CD163 M2 macrophages, further promoting EMT markers. Similar to the previous reporting that stromal EMT gene signature affects GC prognosis and immunotherapy responsiveness (Zheng and Li, 2020;Liu et al, 2021). The combined PLXDC2/EMT/M2 macrophages axis may affect GC outcome and immunotherapy responsiveness.…”
Section: Discussionsupporting
confidence: 89%
“…Our study identified the TME-related gene PLXDC2 in a highstromal population and had a prognostic signature correlated to the CD163 M2 macrophages, further promoting EMT markers. Similar to the previous reporting that stromal EMT gene signature affects GC prognosis and immunotherapy responsiveness (Zheng and Li, 2020;Liu et al, 2021). The combined PLXDC2/EMT/M2 macrophages axis may affect GC outcome and immunotherapy responsiveness.…”
Section: Discussionsupporting
confidence: 89%
“…Immune surveillance is able to monitor, detect, and destroy cancer cells; however, as tumor progresses, cancer cells develop various mechanisms of immune evasion, leading to the development and the invasiveness of the tumor. A highly immunosuppressive microenvironment has been recently associated with the cross-talk between non-tumor-cell mesenchymal stromal cells (MSCs) and TAMs [ 121 ]. Namely, the differentiation from myeloid cells into M2-polarized macrophages, which, as mentioned before, are extremely immunosuppressive, seems to be mainly driven by exosomes produced by MSCs.…”
Section: Immunotherapy and Tme In Gastric Cancermentioning
confidence: 99%
“…Namely, the differentiation from myeloid cells into M2-polarized macrophages, which, as mentioned before, are extremely immunosuppressive, seems to be mainly driven by exosomes produced by MSCs. Moreover, the interactions between pro-inflammatory macrophages and MSCs, mainly mediated by CD54, can lead to an increase in the immunosuppressive activity of MSCs [ 121 ]. As such, the blockade of such a network between MSCs and TAMs may represent a new therapeutic target to exploit in order to restore immune tolerance and improve clinical outcomes in GC patients.…”
Section: Immunotherapy and Tme In Gastric Cancermentioning
confidence: 99%
“…Another source of EVs secretion is tumor-infiltrated Mesenchymal Stem Cells (MSC) derived from bone marrow for promoting regeneration, immune adaptation, and modulation of the TME [ 84 ]. In fact, a recent study showed that tumor-infiltrated MSCs secrete EVs for facilitating M2-like TAM polarization and promoting breast and gastric cancer (GC) progression [ 85 ].…”
Section: Heterogeneous Tam Polarizationmentioning
confidence: 99%